Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
During the last 3 months Amylyx Pharmaceuticals Inc insiders bought 100.8k USD , and sold 5.7m USD worth of shares. The stock price has increased by 21% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/amlx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Mar 2, 2026
by
Frates James M
, who
sold
114.9k USD
worth of
AMLX shares.
During the last 3 months Amylyx Pharmaceuticals Inc insiders bought 100.8k USD , and sold 5.7m USD worth of shares. The stock price has increased by 21% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/amlx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Mar 2, 2026
by
Frates James M
, who
sold
114.9k USD
worth of
AMLX shares.
Amylyx Pharmaceuticals Inc
Glance View
Amylyx Pharmaceuticals, Inc. operates as a biopharmaceutical company, which provides disease-modifying solutions for neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 205 full-time employees. The company went IPO on 2022-01-07. The firm is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The firm is pursuing commercialization of its product candidate, AMX0035. AMX0035 is an investigational product comprised of two complementary active agents, sodium phenylbutyrate (PB) and taurursodiol (TURSO) also known as ursodoxicoltaurine. AMX0035 is designed to target the endoplasmic reticulum and mitochondrial-dependent neuronal degeneration pathways in ALS and other neurodegenerative diseases. AMX0035 keep neurons alive under a variety of different conditions and stresses, including in in vitro models of neurodegeneration, endoplasmic reticulum stress, mitochondrial dysfunction, oxidative stress and disease-specific models of a variety of other conditions, as well as in vivo models of Alzheimer’s Disease (AD) and multiple sclerosis.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.